
Aytu BioScience
Update in progressAYTU (NasdaqCM)
- SectorHealthcare
- IndustryDrug Manufacturers - Specialty & Generic
Aytu Biopharma, Inc. is a pharmaceutical company focused on commercializing prescription medicines in the United States and internationally. Its ADHD portfolio includes Adzenys XR-ODT (6+), Cotempla XR-ODT (6–17), and Metadate CD. The pediatric line also includes Karbinal ER (antihistamine for 2+), and Poly-Vi-Flor and Tri-Vi-Flor fluoride-based multivitamins for infants and children. Formerly Aytu BioScience, it renamed in 2021 and is headquartered in Denver, Colorado.
Company
- MarketNasdaqCM (NCM)
- LocationUnited States
- CEOMr. Joshua R. Disbrow
- Employees82
- Websiteaytubio.com
Identifiers
- ISINUS0547548745
- FIGIBBG000VC2PT9
- CUSIP054754106
- CIK0001385818